|
Status |
Public on Jan 01, 2017 |
Title |
CD86 regulates a pro-survival signal in myeloma cells |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
While multiple myeloma patient prognosis has improved over the past decade, research towards discovery of new therapeutic avenues is important, and could lead to a cure for this chronic plasma cell malignancy. Data analysis from a myeloma patient database shows that the CD28-CD86 signaling module may provide a survival advantage in myeloma cells that negatively impacts patient outcome. Here we show that blocking the CD28-CD86 pathway, by silencing or with CTLA-4-Ig, leads to myeloma cell death. Blockade of this pathway leads to downregulation of nutrient transporters, integrins, and IRF4, a known myeloma survival factor. Our data also indicate that CD86, the canonical "ligand" in this pathway, is mediating a pro-survival signal via the cytosolic domain that has not been previously described. These findings indicate that blockade of this pathway is a promising therapeutic avenue for myeloma, as it leads to modulation of different processes important in cell viability.
|
|
|
Overall design |
The myeloma cell lines MM.1s, RPMI8226, KMS18, and RPMI8226 that overexpresses the anti-apoptotic protein Mcl1 were transfected with short hairpin RNAs targeting CD28, CD86, Gapdh (control), or empty vector (pLK0.1) control and gene expression analysis was performed by RNA-seq.
|
|
|
Contributor(s) |
Gavile CM, Barwick BG, Lawrence BH |
Citation(s) |
29296880 |
|
Submission date |
Nov 03, 2016 |
Last update date |
Mar 28, 2022 |
Contact name |
Benjamin G Barwick |
E-mail(s) |
benjamin.barwick@emory.edu
|
Phone |
(404) 285-2964
|
Organization name |
Emory University
|
Department |
Hematology and Medical Oncology
|
Lab |
Barwick Lab
|
Street address |
1365 Clifton Rd. NE WCI-C 4th Floor Benches 36-37
|
City |
Atlanta |
State/province |
GA |
ZIP/Postal code |
30322 |
Country |
USA |
|
|
Platforms (1) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
Samples (16)
|
|
Relations |
BioProject |
PRJNA352410 |
SRA |
SRP092559 |